Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients

被引:21
|
作者
Schaner, Marci E.
Davidson, Ben
Skrede, Martina
Reich, Reuven
Florenes, Vivi Ann
Risberg, Bjorn
Berner, Aasmund
Goldberg, Iris
Givant-Horwitz, Vered
Trope, Claes G.
Kristensen, Gunnar B.
Nesland, Jahn M.
Borresen-Dale, Anne-Lise [1 ]
机构
[1] Univ Oslo, Norwegian Radium Hosp, Dept Genet, N-0310 Oslo, Norway
[2] Stanford Univ, Sch Med, Dept Biochem MES, Stanford, CA 94305 USA
[3] Univ Oslo, Norwegian Radium Hosp, Dept Pathol, N-0310 Oslo, Norway
[4] Hebrew Univ Jerusalem, Fac Med, Dept Pharmacol & Expt Therapeut, IL-91120 Jerusalem, Israel
[5] Univ Oslo, Norwegian Radium Hosp, Dept Gynecol Oncol, N-0310 Oslo, Norway
关键词
D O I
10.1186/1476-4598-4-26
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: While numerous studies have characterized primary ovarian tumors, little information is available regarding expression patterns of metastatic sites of this cancer. To define sets of genes that distinguish primary and metastatic ovarian tumors, we used cDNA microarrays to characterize global gene expression patterns in 38 effusions ( 28 peritoneal, 10 pleural) and 8 corresponding primary ovarian tumors, and searched for associations between expression patterns and clinical parameters. Results: We observed multidimensional variation in expression patterns among the cancers. Coordinate variation in expression of genes from two chromosomal regions, 8q and 19q, was seen in subsets of the cancers indicating possible amplifications in these regions. A set of 112 unique genes of known function was differentially expressed between primary tumors and effusions using supervised analysis. Relatively few differences were seen between effusions isolated from the pleural and peritoneal cavities or between effusions from patients diagnosed with stage III and stage IV cancers. A set of 84 unique genes was identified that distinguished high from lower grade ovarian cancers. The results were corroborated using immunocytochemistry, mRNA in situ hybridization, and immunoblotting. Conclusion: The extensive variation in expression patterns observed underscores the molecular heterogeneity of ovarian cancer, but suggests a similar molecular profile for ovarian carcinoma cells in serosal cavities.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients
    Marci E Schaner
    Ben Davidson
    Martina Skrede
    Reuven Reich
    Vivi Ann Flørenes
    Björn Risberg
    Aasmund Berner
    Iris Goldberg
    Vered Givant-Horwitz
    Claes G Tropè
    Gunnar B Kristensen
    Jahn M Nesland
    Anne-Lise Børresen-Dale
    Molecular Cancer, 4
  • [2] HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases
    Hetland, Thea Eline
    Holth, Arild
    Kaern, Janne
    Florenes, Vivi Ann
    Trope, Claes G.
    Davidson, Ben
    VIRCHOWS ARCHIV, 2012, 460 (05) : 505 - 513
  • [3] HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases
    Thea Eline Hetland
    Arild Holth
    Janne Kærn
    Vivi Ann Flørenes
    Claes G. Tropé
    Ben Davidson
    Virchows Archiv, 2012, 460 : 505 - 513
  • [4] IMMUNOCYTOCHEMICAL EXPRESSION OF K-RAS IN SEROUS EFFUSIONS FROM DIFFERENT PRIMARY TUMORS
    Chatzis, O.
    Sioutopoulou, D.
    Mygdakos, N.
    Fytili, P.
    Charalampidis, C.
    Valeri, R.
    Destouni, C.
    ACTA CYTOLOGICA, 2010, 54 (03) : 475 - 475
  • [5] Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma:: Evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions
    Davidson, B
    Berner, A
    Nesland, JM
    Risberg, B
    Kristensen, GB
    Tropé, CG
    Bryne, M
    HUMAN PATHOLOGY, 2000, 31 (09) : 1081 - 1087
  • [6] Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions
    Davidson, Ben
    Stavnes, Helene Tuft
    Holth, Arild
    Chen, Xu
    Yang, Yanqin
    Shih, Ie-Ming
    Wang, Tian-Li
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2011, 15 (03) : 535 - 544
  • [7] CD 56 expression in serous invasive ovarian cancer and serous ovarian borderline tumors
    Pokieser, W.
    Hauptmann, S.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 151 - 151
  • [8] Clinical Relevance of Multidrug Resistance Gene Expression in Ovarian Serous Carcinoma Effusions
    Gillett, Jean-Pierre
    Wang, Junbai
    Calcagno, Anna Maria
    Green, Lisa J.
    Varma, Sudhir
    Elstrand, Mari Bunkholt
    Trope, Claes G.
    Ambudkar, Suresh V.
    Davidson, Ben
    Gottesman, Michael M.
    MOLECULAR PHARMACEUTICS, 2011, 8 (06) : 2080 - 2088
  • [9] Calreticulin expression is reduced in high-grade ovarian serous carcinoma effusions compared with primary tumors and solid metastases
    Vaksman, Olga
    Davidson, Ben
    Trope, Claes
    Reich, Reuven
    HUMAN PATHOLOGY, 2013, 44 (12) : 2677 - 2683
  • [10] Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy
    Santin, AD
    Zhan, FH
    Bellone, S
    Palmieri, M
    Cane, S
    Bignotti, E
    Anfossi, S
    Gokden, M
    Dunn, D
    Roman, JJ
    O'Brien, TJ
    Tian, EM
    Cannon, MJ
    Shaughnessy, J
    Pecorelli, S
    INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (01) : 14 - 25